Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7059)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2022 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol 2022; 14(9): 1604-1621 [PMID: 36187393 DOI: 10.4251/wjgo.v14.i9.1604] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i9/1604.htm |
| Number | Citing Articles |
| 1 |
Lidi Ma, Cheng Zhang, Yuhua Wen, Kaili Xing, Shaohua Li, Zhijun Geng, Shuting Liao, Shasha Yuan, Xinming Li, Chong Zhong, Jing Hou, Jie Zhang, Mingyong Gao, Baojun Xu, Rongping Guo, Wei Wei, Chuanmiao Xie, Lianghe Lu. Imaging-based surrogate classification for risk stratification of hepatocellular carcinoma with microvascular invasion to adjuvant hepatic arterial infusion chemotherapy: a multicenter retrospective study. International Journal of Surgery 2025; 111(1): 872 doi: 10.1097/JS9.0000000000001903
|
| 2 |
Jeng-Shiun Du, Shih-Hsien Hsu, Shen-Nien Wang. The Current and Prospective Adjuvant Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(7): 1422 doi: 10.3390/cancers16071422
|
| 3 |
Luyang Wang, Le Tong, Zecheng Xiong, Yi Chen, Ping Zhang, Yan Gao, Jing Liu, Lei Yang, Chunqi Huang, Gaoqi Ye, Jing Du, Huibiao Liu, Wei Yang, Ying Wang. Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02808-7
|
| 4 |
Yichen Peng, Xia Wu, Yurong Zhang, Yue Yin, Xianglin Chen, Ding Zheng, Jing Wang. An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 2305 doi: 10.2147/JHC.S413996
|
| 5 |
Jiaming Liang, Meifeng Chen, Guohong Yan, Pham Thi Thai Hoa, Shuxin Wei, Hailian Huang, Qichong Xie, Xiaoling Luo, Shutian Mo, Chuangye Han. Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-024-01550-6
|
| 6 |
Jiageng Guo, Xinya Jiang, Jing Lian, Huaying Li, Fan Zhang, Jinling Xie, Jiagang Deng, Xiaotao Hou, Zhengcai Du, Erwei Hao. Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1431423
|
| 7 |
Hui Shao, Jingyan Chen, Ali Li, Lili Ma, Yongzhi Tang, Huazhong Chen, Yongping Chen, Junyan Liu. Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway. Applied Biochemistry and Biotechnology 2023; 195(8): 5217 doi: 10.1007/s12010-023-04511-z
|
| 8 |
Yanyan Ye, Ying Wang, Haoqian Xu, Fengming Yi. Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02955-5
|
| 9 |
Rui Luo, Chongkai Fang, Chuyao Chen, Ying Zhang, Ruiwei Yao, Jinan Wang, Hanqian Shi, Kunliang Feng, Mingli Hu, Chong Zhong. Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1212116
|
| 10 |
Xiaoying Xu, Yu Liu, Yanyan Liu, Yahan Yu, Mingqi Yang, Ligong Lu, Leung Chan, Bing Liu. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02547-9
|
| 11 |
Mayank Sharma, Payal Dande, Apeksha Saraf, Jineetkumar Gawad, Rahul Maheshwari, Sumel Ashique. Advancements in Cancer Research: Exploring Diagnostics and Therapeutic Breakthroughs. 2025; : 194 doi: 10.2174/9789815305906125010015
|
| 12 |
Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang. Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities. Cancer Science 2024; 115(7): 2159 doi: 10.1111/cas.16194
|
| 13 |
Yi-Hao Yen, Fang-Ying Kuo, Hock-Liew Eng, Yueh-Wei Liu, Chee-Chien Yong, Wei-Feng Li, Chih-Chi Wang, Chih-Yun Lin, Tyng-Yuan Jang. Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma. PLOS ONE 2023; 18(11): e0292144 doi: 10.1371/journal.pone.0292144
|
| 14 |
Bowen Men, Huzhe Cui, Zhezhu Han, Xiuying Jin, Qiang Xu, Yongmin Jin, Zhengri Piao, Songnan Zhang. Evaluation of the efficacy of transarterial chemoembolization combined with microwave ablation followed by adjuvant therapy in patients with hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1337396
|
| 15 |
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and management. Liver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
|
| 16 |
Nasim Rahimi-Farsi, Fatemeh Bostanian, Taha Shahbazi, Fatemeh Sadat Shamsinejad, Mansoor Bolideei, Parvin Mohseni, Alireza Zangooie, Farnaz Boustani, Hamed Shoorei. Novel oncogenes and tumor suppressor genes in Hepatocellular Carcinoma: Carcinogenesis, progression, and therapeutic targets. Gene 2025; 941: 149229 doi: 10.1016/j.gene.2025.149229
|